首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil
【24h】

Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil

机译:巴西肝细胞癌隐匿性乙型肝炎病毒感染率低且丙型肝炎病毒基因型3频率高

获取原文
           

摘要

Occult hepatitis B virus (HBV) infection has been reported among patients with hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC). Our aim was to evaluate the presence of occult HBV infection in patients with HCV-related liver cirrhosis (LC) with or without HCC in S?o Paulo, Brazil. Serum and liver tissue samples from 50 hepatitis B surface antigen-negative patients with HCV-related LC who underwent liver transplantation at the University of S?o Paulo School of Medicine Hospital from 1993 to 2004 were divided into groups with LC only (N = 33) and with LC plus HCC (N = 17). HBV DNA was assayed for serum and paraffin-embedded liver tissue (tumoral and non-tumoral) using real time PCR and only 1 case with HCC had HBV DNA-positive serum. All liver samples were negative. HCV genotype 3 was detected in 17/39 (43.7%) cases. In conclusion, using a sensitive real time PCR directed to detect HBV variants circulating in Brazil, occult hepatitis B infection was not found among HCV-positive cirrhotic patients and was rarely found among HCV-positive HCC patients. These results are probably related to the low prevalence of HBV infection in our population. Furthermore, we have also shown that HCV genotype 3 is frequently found in Brazilian cirrhotic patients, particularly when they also have HCC. More studies involving a large number of cases should be carried out to confirm these data and to further characterize Brazilian HCV genotype isolates to elucidate genetic features that might be related to its carcinogenic potential.
机译:据报道,丙型肝炎病毒(HCV)感染和肝细胞癌(HCC)患者之间存在隐匿性乙型肝炎病毒(HBV)感染。我们的目的是评估巴西圣保罗的HCV相关性肝硬化(LC)患者是否伴有HCC的隐匿性HBV感染。将1993年至2004年在圣保罗大学医学院医院进行肝移植的50例HCV相关性LC的乙型肝炎表面抗原阴性患者的血清和肝组织样本分为仅LC组(N = 33 )以及LC和HCC(N = 17)。使用实时PCR检测HBV DNA的血清和石蜡包埋的肝组织(肿瘤和非肿瘤),只有1例HCC患者的HBV DNA阳性血清。所有肝样本均为阴性。在17/39(43.7%)病例中检测到HCV基因型3。总之,使用用于检测在巴西传播的HBV变异的灵敏实时PCR,在HCV阳性肝硬化患者中未发现隐匿性乙型肝炎感染,而在HCV阳性HCC患者中很少发现隐匿性乙型肝炎感染。这些结果可能与我们人群中HBV感染率低有关。此外,我们还表明,在巴西肝硬化患者中经常发现HCV基因型3,特别是当他们也患有HCC时。应该进行更多涉及大量病例的研究,以确认这些数据并进一步鉴定巴西HCV基因型分离株的特征,以阐明可能与其致癌潜力相关的遗传特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号